Zobrazeno 1 - 10
of 122
pro vyhledávání: '"Wanhe, Wang"'
Publikováno v:
Molecular Cancer, Vol 23, Iss 1, Pp 1-23 (2024)
Abstract Breast cancer (BC) is the most frequent malignant cancer diagnosis and is a primary factor for cancer deaths in women. The clinical subtypes of BC include estrogen receptor (ER) positive, progesterone receptor (PR) positive, human epidermal
Externí odkaz:
https://doaj.org/article/d57aa245820d48ac86b7e2caee8cb632
Publikováno v:
Genes and Diseases, Vol 10, Iss 6, Pp 2260-2262 (2023)
Externí odkaz:
https://doaj.org/article/feccfda50dac4875b717ecad25a6472b
Autor:
Hai-Jing Zhong, Wanhe Wang, Wei Zhou, Jia-Xin Liang, Yung-Chi Cheng, Dik-Lung Ma, Chung-Hang Leung
Publikováno v:
Genes and Diseases, Vol 10, Iss 5, Pp 1735-1738 (2023)
Externí odkaz:
https://doaj.org/article/8694749e0e4a40a29383069dddab752f
Publikováno v:
Biosensors, Vol 14, Iss 8, p 369 (2024)
As a commonly used metal ion, iron(II) (Fe2+) ions pose a potential threat to ecosystems and human health. Therefore, it is particularly important to develop analytical techniques for the rapid and accurate detection of Fe2+ ions. However, the develo
Externí odkaz:
https://doaj.org/article/6b8123f31b954511bc1153243f016e28
Publikováno v:
Catalysts, Vol 14, Iss 6, p 338 (2024)
A novel protocol facilitated by Na2SO3 that enhances the efficiency of palladium-catalyzed Heck coupling and the homo-coupling reactions of arylhydrazines. This innovative method enables the effective construction of a diverse array of cinnamate deri
Externí odkaz:
https://doaj.org/article/38583504531b446dace6758a1220b742
Autor:
Ying-Qi Song, Guo-Dong Li, Dou Niu, Feng Chen, Shaozhen Jing, Vincent Kam Wai Wong, Wanhe Wang, Chung-Hang Leung
Publikováno v:
Journal of Pharmaceutical Analysis, Vol 13, Iss 5, Pp 514-522 (2023)
Temozolomide (TMZ) is an anticancer agent used to treat glioblastoma, typically following radiation therapy and/or surgical resection. However, despite its effectiveness, at least 50% of patients do not respond to TMZ, which is associated with repair
Externí odkaz:
https://doaj.org/article/bd7a50fd2f1a4f82ae50a7f0e1695400
Publikováno v:
Acta Materia Medica, Vol 2, Iss 1, Pp 42-53 (2023)
Proteolysis-targeting chimeras (PROTACs), a novel targeted protein degradation technology for potential clinical drug discovery, is composed of a protein-targeting ligand covalently linked to an E3 ligase ligand. Through recruiting E3 ligase to targe
Externí odkaz:
https://doaj.org/article/cb8367166f7b484d9b37f658ec759154
Publikováno v:
Genes and Diseases, Vol 9, Iss 6, Pp 1674-1688 (2022)
Triple-negative breast cancer (TNBC) is a highly aggressive and metastasizing cancer that has the worst prognosis out of all breast cancer subtypes. The epithelial–mesenchymal transition (EMT) and cancer stem cells (CSCs) have been proposed as impo
Externí odkaz:
https://doaj.org/article/7732a09d52a34fe0a939d0c908d9e7cc
Publikováno v:
Molecules, Vol 29, Iss 1, p 256 (2024)
Iridium(III) complexes are emerging as a promising tool in the area of detection and therapy due to their prominent photophysical properties, including higher photostability, tunable phosphorescence emission, long-lasting phosphorescence, and high qu
Externí odkaz:
https://doaj.org/article/963cd96e371e4e95989ee9859720156c
Autor:
Shasha Cheng, Guan-Jun Yang, Wanhe Wang, Ying-Qi Song, Chung-Nga Ko, Quanbin Han, Dik-Lung Ma, Chung-Hang Leung
Publikováno v:
Acta Materia Medica, Vol 1, Iss 2, Pp 197-211 (2022)
Enhancer of zeste homolog 2 (EZH2) is activated in breast cancer, particularly in triple-negative breast cancer (TNBC), and is critical for cell invasion. It interacts with embryonic ectoderm development (EED) in maintaining cancer stem cells (CSC) a
Externí odkaz:
https://doaj.org/article/f6467e5fd4954edcb87d4a5a67e130aa